# ZOCOR

Product · id `cardio:fdaprod-nda019766` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [openFDA record NDA019766](<https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>), retrieved 8 November 2026. No person wrote or checked this page.

Browse, condition area: Risk and prevention; Coronary and vascular disease  

## In plain language

A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 13 efficacy supplement approvals on record.

## Technical summary

Drugs@FDA application NDA019766. Original approval 1991-12-23. Efficacy supplement approvals 1995-06-30, 1997-10-31, 1998-03-31, 1998-07-10, 1998-07-10, 1999-08-05, 1999-11-22, 1999-11-22, 2000-04-27, 2000-11-07, 2002-03-21, 2002-10-18, 2003-04-16. 5 products listed.

## The registry's words

- Application: NDA019766
- Brand name: ZOCOR
- Applicant: ORGANON
- Active ingredient: SIMVASTATIN
- Dosage form: TABLET
- Route: ORAL

## Claims, with the population each applies to

## Context: FDA record read by the openFDA feed

Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)

### FDA records an approval of NDA019766 on 1991-12-23.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[68\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[68\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 11 to NDA019766 on 1995-06-30.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[51\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[51\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 21 to NDA019766 on 1997-10-31.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[44\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[44\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 26 to NDA019766 on 1998-07-10.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[74\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[74\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 27 to NDA019766 on 1998-03-31.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[28\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[28\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 28 to NDA019766 on 1998-07-10.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[69\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[69\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 32 to NDA019766 on 1999-08-05.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[79\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[79\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 34 to NDA019766 on 1999-11-22.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[72\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[72\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 36 to NDA019766 on 1999-11-22.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[66\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[66\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 40 to NDA019766 on 2000-04-27.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[75\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[75\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 42 to NDA019766 on 2000-11-07.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[70\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[70\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 52 to NDA019766 on 2002-03-21.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[62\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[62\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 56 to NDA019766 on 2002-10-18.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[52\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[52\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

### FDA records an approval of efficacy supplement 58 to NDA019766 on 2003-04-16.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved uses are in the FDA label, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[49\].submission\_status\_date. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision date as the record writes it.
  2. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: application\_number. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The registry number of the record.
  3. Supports: Drugs@FDA application NDA019766 (openFDA record) (Regulator) <https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA019766>
     Locator: submissions\[49\].submission\_status. Retrieved 2026-11-08T20:51:56Z. Source state: Current. Version fingerprint: 29050f7d53486dd8b2e4c7cbe12aad8177e10f3f857d2290e432cd7be6496fd4.
     How it applies: The decision status as the record writes it.

## Guidance, authorization and access

### Regulatory decision `cardio:fdadec-nda019766-approval`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Approval, 1991-12-23
- Product version: Original application
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-approval`

### Regulatory decision `cardio:fdadec-nda019766-s011`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1995-06-30
- Product version: Efficacy supplement 11
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s011`

### Regulatory decision `cardio:fdadec-nda019766-s021`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1997-10-31
- Product version: Efficacy supplement 21
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s021`

### Regulatory decision `cardio:fdadec-nda019766-s026`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1998-07-10
- Product version: Efficacy supplement 26
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s026`

### Regulatory decision `cardio:fdadec-nda019766-s027`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1998-03-31
- Product version: Efficacy supplement 27
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s027`

### Regulatory decision `cardio:fdadec-nda019766-s028`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1998-07-10
- Product version: Efficacy supplement 28
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s028`

### Regulatory decision `cardio:fdadec-nda019766-s032`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1999-08-05
- Product version: Efficacy supplement 32
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s032`

### Regulatory decision `cardio:fdadec-nda019766-s034`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1999-11-22
- Product version: Efficacy supplement 34
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s034`

### Regulatory decision `cardio:fdadec-nda019766-s036`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1999-11-22
- Product version: Efficacy supplement 36
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s036`

### Regulatory decision `cardio:fdadec-nda019766-s040`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2000-04-27
- Product version: Efficacy supplement 40
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s040`

### Regulatory decision `cardio:fdadec-nda019766-s042`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2000-11-07
- Product version: Efficacy supplement 42
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s042`

### Regulatory decision `cardio:fdadec-nda019766-s052`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2002-03-21
- Product version: Efficacy supplement 52
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s052`

### Regulatory decision `cardio:fdadec-nda019766-s056`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2002-10-18
- Product version: Efficacy supplement 56
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s056`

### Regulatory decision `cardio:fdadec-nda019766-s058`

- Product: ZOCOR (`cardio:fdaprod-nda019766`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2003-04-16
- Product version: Efficacy supplement 58
- Pathway: NDA
- Submission: NDA019766
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-nda019766-s058`

## Connected pages

- Registry active ingredient is this drug: Simvastatin (`cardio:simvastatin`)

## Provenance

Content hash: f6e815af675372024b9b8bc083640ced45744609f4686a2accc6c4b502a995a4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
